{"title":"Breast","description":null,"products":[{"product_id":"abemaciclib-100-mg","title":"Abemaciclib 100mg","description":"\u003cp class=\"p1\"\u003eAbemaciclib is used with hormone therapy for HR-positive, HER2-negative early breast cancer when there is a high risk of the cancer coming back after surgery.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eIt is also used for HR-positive, HER2-negative breast cancer that is locally advanced or has spread, either as a first treatment with an aromatase inhibitor or after earlier hormone therapy with fulvestrant. In some adults whose advanced HR-positive, HER2-negative breast cancer has worsened after hormone therapy and chemotherapy, abemaciclib may be used on its own.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eUsual adult dose range: 50mg to 200mg twice daily; many breast cancer regimens start at 150mg twice daily with hormone therapy, or 200mg twice daily when used alone, with lower doses used if side effects occur.\u003c\/p\u003e","brand":"Find-A-Drug","offers":[{"title":"Default Title","offer_id":63547335115121,"sku":"52001","price":0.0,"currency_code":"NZD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1006\/1371\/8385\/files\/meds-compressed_1bccc7ad-48c8-4dc8-815b-7b522f191894.png?v=1786417522"},{"product_id":"abemaciclib-150-mg","title":"Abemaciclib 150mg","description":"\u003cp class=\"p1\"\u003eAbemaciclib is used with hormone therapy for HR-positive, HER2-negative early breast cancer when there is a high risk of the cancer coming back after surgery.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eIt is also used for HR-positive, HER2-negative breast cancer that is locally advanced or has spread, either as a first treatment with an aromatase inhibitor or after earlier hormone therapy with fulvestrant. In some adults whose advanced HR-positive, HER2-negative breast cancer has worsened after hormone therapy and chemotherapy, abemaciclib may be used on its own.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eUsual adult dose range: 50mg to 200mg twice daily; many breast cancer regimens start at 150mg twice daily with hormone therapy, or 200mg twice daily when used alone, with lower doses used if side effects occur.\u003c\/p\u003e","brand":"Find-A-Drug","offers":[{"title":"Default Title","offer_id":63547335147889,"sku":"52002","price":1.0,"currency_code":"NZD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1006\/1371\/8385\/files\/meds-compressed_7c653208-3116-4b8d-9100-8d7f6ead3780.png?v=1786417544"},{"product_id":"abemaciclib-200-mg","title":"Abemaciclib 200mg","description":"\u003cp class=\"p1\"\u003eAbemaciclib is used with hormone therapy for HR-positive, HER2-negative early breast cancer when there is a high risk of the cancer coming back after surgery.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eIt is also used for HR-positive, HER2-negative breast cancer that is locally advanced or has spread, either as a first treatment with an aromatase inhibitor or after earlier hormone therapy with fulvestrant. In some adults whose advanced HR-positive, HER2-negative breast cancer has worsened after hormone therapy and chemotherapy, abemaciclib may be used on its own.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eUsual adult dose range: 50mg to 200mg twice daily; many breast cancer regimens start at 150mg twice daily with hormone therapy, or 200mg twice daily when used alone, with lower doses used if side effects occur.\u003c\/p\u003e","brand":"Find-A-Drug","offers":[{"title":"Default Title","offer_id":63547335180657,"sku":"52003","price":2.0,"currency_code":"NZD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1006\/1371\/8385\/files\/meds-compressed_6340d48b-31cb-4287-8083-a41d2d088d34.png?v=1786417587"},{"product_id":"abemaciclib-50-mg","title":"Abemaciclib 50mg","description":"\u003cp class=\"p1\"\u003eAbemaciclib is used with hormone therapy for HR-positive, HER2-negative early breast cancer when there is a high risk of the cancer coming back after surgery.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eIt is also used for HR-positive, HER2-negative breast cancer that is locally advanced or has spread, either as a first treatment with an aromatase inhibitor or after earlier hormone therapy with fulvestrant. In some adults whose advanced HR-positive, HER2-negative breast cancer has worsened after hormone therapy and chemotherapy, abemaciclib may be used on its own.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eUsual adult dose range: 50mg to 200mg twice daily; many breast cancer regimens start at 150mg twice daily with hormone therapy, or 200mg twice daily when used alone, with lower doses used if side effects occur.\u003c\/p\u003e","brand":"Find-A-Drug","offers":[{"title":"Default Title","offer_id":63547335213425,"sku":"52004","price":3.0,"currency_code":"NZD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1006\/1371\/8385\/files\/meds-compressed_4b41678a-1b00-4f10-8ee7-81f4d70e8ee5.png?v=1786417603"},{"product_id":"alpelisib-150-mg","title":"Alpelisib 150mg","description":"\u003cp\u003e\u003cspan lang=\"EN-US\"\u003eAlpelisib is used with fulvestrant for HR-positive, HER2-negative breast cancer that has a PIK3CA mutation, is advanced or metastatic, and has worsened after hormone therapy.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan lang=\"EN-US\"\u003eA different alpelisib product is used for severe PIK3CA-related overgrowth spectrum, a group of rare conditions where tissue grows too much because of a PIK3CA gene change.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan lang=\"EN-US\"\u003eUsual adult dose range: 200mg to 300mg once daily with food for breast cancer; lower or age-based doses are used for PIK3CA-related overgrowth conditions.\u003c\/span\u003e\u003c\/p\u003e","brand":"Find-A-Drug","offers":[{"title":"Default Title","offer_id":63547336229233,"sku":"52009","price":8.0,"currency_code":"NZD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1006\/1371\/8385\/files\/meds-compressed_f708bc2c-ebfb-47b8-890a-877733e4b725.png?v=1786417725"},{"product_id":"alpelisib-200-mg","title":"Alpelisib 200mg","description":"\u003cp\u003e\u003cspan lang=\"EN-US\"\u003eAlpelisib is used with fulvestrant for HR-positive, HER2-negative breast cancer that has a PIK3CA mutation, is advanced or metastatic, and has worsened after hormone therapy.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan lang=\"EN-US\"\u003eA different alpelisib product is used for severe PIK3CA-related overgrowth spectrum, a group of rare conditions where tissue grows too much because of a PIK3CA gene change.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan lang=\"EN-US\"\u003eUsual adult dose range: 200mg to 300mg once daily with food for breast cancer; lower or age-based doses are used for PIK3CA-related overgrowth conditions.\u003c\/span\u003e\u003c\/p\u003e","brand":"Find-A-Drug","offers":[{"title":"Default Title","offer_id":63547336294769,"sku":"52010","price":9.0,"currency_code":"NZD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1006\/1371\/8385\/files\/meds-compressed_262f5f71-48d0-4b28-92d9-da711f99945b.png?v=1786417738"},{"product_id":"alpelisib-50-mg","title":"Alpelisib 50mg","description":"\u003cp\u003e\u003cspan lang=\"EN-US\"\u003eAlpelisib is used with fulvestrant for HR-positive, HER2-negative breast cancer that has a PIK3CA mutation, is advanced or metastatic, and has worsened after hormone therapy.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan lang=\"EN-US\"\u003eA different alpelisib product is used for severe PIK3CA-related overgrowth spectrum, a group of rare conditions where tissue grows too much because of a PIK3CA gene change.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan lang=\"EN-US\"\u003eUsual adult dose range: 200 mg to 300 mg once daily with food for breast cancer; lower or age-based doses are used for PIK3CA-related overgrowth conditions.\u003c\/span\u003e\u003c\/p\u003e","brand":"Find-A-Drug","offers":[{"title":"Default Title","offer_id":63547336360305,"sku":"52011","price":10.0,"currency_code":"NZD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1006\/1371\/8385\/files\/meds-compressed_e9994231-780c-4edb-95dd-ad2a7b5bbde4.png?v=1786417774"},{"product_id":"everolimus-10-mg","title":"Everolimus 10mg","description":"\u003cp\u003e\u003cspan lang=\"EN-US\"\u003eEverolimus is used with exemestane for HR-positive, HER2-negative advanced breast cancer in postmenopausal women after earlier hormone treatment has stopped working.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan lang=\"EN-US\"\u003eIt is used for advanced renal cell carcinoma after certain earlier targeted treatments.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan lang=\"EN-US\"\u003eIt is also used for some neuroendocrine tumours and for certain tuberous sclerosis-related tumours or seizures.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan lang=\"EN-US\"\u003eUsual adult dose range: 2.5mg to 10mg once daily, depending on the condition, combination treatment, blood levels, side effects, and kidney or liver function.\u003c\/span\u003e\u003c\/p\u003e","brand":"Find-A-Drug","offers":[{"title":"Default Title","offer_id":63547337343345,"sku":"52040","price":39.0,"currency_code":"NZD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1006\/1371\/8385\/files\/meds-compressed_aacf5936-5d20-48c0-bcc3-e2ff0c53212f.png?v=1786419243"},{"product_id":"everolimus-5-mg","title":"Everolimus 5mg","description":"\u003cp\u003e\u003cspan lang=\"EN-US\"\u003eEverolimus is used with exemestane for HR-positive, HER2-negative advanced breast cancer in postmenopausal women after earlier hormone treatment has stopped working.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan lang=\"EN-US\"\u003eIt is used for advanced renal cell carcinoma after certain earlier targeted treatments.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan lang=\"EN-US\"\u003eIt is also used for some neuroendocrine tumours and for certain tuberous sclerosis-related tumours or seizures.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan lang=\"EN-US\"\u003eUsual adult dose range: 2.5mg to 10mg once daily, depending on the condition, combination treatment, blood levels, side effects, and kidney or liver function.\u003c\/span\u003e\u003c\/p\u003e","brand":"Find-A-Drug","offers":[{"title":"Default Title","offer_id":63547337408881,"sku":"52041","price":40.0,"currency_code":"NZD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1006\/1371\/8385\/files\/meds-compressed_7bfe5b6c-eb35-46dd-97f3-fcf0f815134b.png?v=1786419260"},{"product_id":"lapatinib-250-mg","title":"Lapatinib 250mg","description":"\u003cp class=\"MsoNormal\" style=\"margin-bottom: 5.0pt; line-height: 105%;\"\u003e\u003cspan lang=\"EN-US\"\u003eLapatinib is used with capecitabine for HER2-positive breast cancer that is advanced or has spread after earlier HER2-directed treatment.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"MsoNormal\" style=\"margin-bottom: 5.0pt; line-height: 105%;\"\u003e\u003cspan lang=\"EN-US\"\u003eIt can also be used with letrozole for postmenopausal women with hormone receptor-positive, HER2-positive metastatic breast cancer when hormone treatment is appropriate.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"MsoNormal\"\u003e\u003cspan lang=\"EN-US\"\u003eUsual adult dose range: 1,250 mg to 1,500 mg once daily, depending on the breast cancer combination treatment being used.\u003c\/span\u003e\u003c\/p\u003e","brand":"Find-A-Drug","offers":[{"title":"Default Title","offer_id":63547337638257,"sku":"52048","price":47.0,"currency_code":"NZD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1006\/1371\/8385\/files\/meds-compressed_76ed1bb7-e2a9-4bd6-8f1e-04f3b1005df7.png?v=1786419531"},{"product_id":"neratinib-40-mg","title":"Neratinib 40mg","description":"\u003cp\u003e\u003cspan lang=\"EN-US\"\u003eNeratinib is used after trastuzumab-based treatment for early HER2-positive breast cancer to lower the chance of the cancer coming back.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan lang=\"EN-US\"\u003eIt is also used with capecitabine for HER2-positive breast cancer that is advanced or has spread after at least two earlier HER2-directed treatments.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan lang=\"EN-US\"\u003eUsual adult dose range: 120mg to 240mg once daily with food, often increased stepwise at the start or reduced if side effects occur.\u003c\/span\u003e\u003c\/p\u003e","brand":"Find-A-Drug","offers":[{"title":"Default Title","offer_id":63547337933169,"sku":"52057","price":56.0,"currency_code":"NZD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1006\/1371\/8385\/files\/meds-compressed_38959c69-89f2-4cdc-8357-c08d339293a0.png?v=1786427960"},{"product_id":"olaparib-150-mg","title":"Olaparib 150mg","description":"\u003cp\u003e\u003cspan lang=\"EN-US\"\u003eOlaparib is used for ovarian, fallopian tube, or primary peritoneal cancer, especially as maintenance treatment when the cancer has responded to platinum-based chemotherapy and has BRCA mutation or other homologous recombination repair features.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan lang=\"EN-US\"\u003eIt is used for HER2-negative breast cancer with an inherited BRCA mutation in some early high-risk or metastatic settings.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan lang=\"EN-US\"\u003eIt is also used for pancreatic cancer with an inherited BRCA mutation after platinum chemotherapy and for metastatic castration-resistant prostate cancer with certain DNA repair gene changes.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan lang=\"EN-US\"\u003eUsual adult tablet dose range: 200mg to 300mg twice daily; the usual starting tablet dose is 300mg twice daily, with lower doses used if side effects or interacting medicines require adjustment.\u003c\/span\u003e\u003c\/p\u003e","brand":"Find-A-Drug","offers":[{"title":"Default Title","offer_id":63547338162545,"sku":"52063","price":62.0,"currency_code":"NZD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1006\/1371\/8385\/files\/meds-compressed_ec0195a4-ea2b-47d6-bb02-1123a8060cd2.png?v=1786428247"},{"product_id":"olaparib-50-mg","title":"Olaparib 50mg","description":"\u003cp\u003e\u003cspan lang=\"EN-US\"\u003eOlaparib is used for ovarian, fallopian tube, or primary peritoneal cancer, especially as maintenance treatment when the cancer has responded to platinum-based chemotherapy and has BRCA mutation or other homologous recombination repair features.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan lang=\"EN-US\"\u003eIt is used for HER2-negative breast cancer with an inherited BRCA mutation in some early high-risk or metastatic settings.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan lang=\"EN-US\"\u003eIt is also used for pancreatic cancer with an inherited BRCA mutation after platinum chemotherapy and for metastatic castration-resistant prostate cancer with certain DNA repair gene changes.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan lang=\"EN-US\"\u003eUsual adult tablet dose range: 200mg to 300mg twice daily; the usual starting tablet dose is 300mg twice daily, with lower doses used if side effects or interacting medicines require adjustment.\u003c\/span\u003e\u003c\/p\u003e","brand":"Find-A-Drug","offers":[{"title":"Default Title","offer_id":63547338195313,"sku":"52064","price":63.0,"currency_code":"NZD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1006\/1371\/8385\/files\/meds-compressed_a4fe4211-91a5-48ff-8646-ab6f4506ae20.png?v=1786428261"},{"product_id":"palbociclib-100-mg","title":"Palbociclib 100mg","description":"\u003cp\u003e\u003cspan lang=\"EN-US\"\u003ePalbociclib is used with an aromatase inhibitor as a first hormone-based treatment for HR-positive, HER2-negative breast cancer that is advanced or has spread.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan lang=\"EN-US\"\u003eIt is also used with fulvestrant when HR-positive, HER2-negative advanced or metastatic breast cancer has worsened after earlier hormone therapy.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan lang=\"EN-US\"\u003ePeople who have not gone through menopause usually receive ovarian-suppression treatment as well.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan lang=\"EN-US\"\u003eUsual adult dose range: 75mg to 125mg once daily on days 1 to 21 of each 28-day cycle; the usual starting dose is 125mg once daily.\u003c\/span\u003e\u003c\/p\u003e","brand":"Find-A-Drug","offers":[{"title":"Default Title","offer_id":63547338260849,"sku":"52066","price":65.0,"currency_code":"NZD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1006\/1371\/8385\/files\/meds-compressed_25cb7d4a-376b-427b-9361-4a973f8de73d.png?v=1786428322"},{"product_id":"palbociclib-125-mg","title":"Palbociclib 125mg","description":"\u003cp\u003e\u003cspan lang=\"EN-US\"\u003ePalbociclib is used with an aromatase inhibitor as a first hormone-based treatment for HR-positive, HER2-negative breast cancer that is advanced or has spread.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan lang=\"EN-US\"\u003eIt is also used with fulvestrant when HR-positive, HER2-negative advanced or metastatic breast cancer has worsened after earlier hormone therapy.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan lang=\"EN-US\"\u003ePeople who have not gone through menopause usually receive ovarian-suppression treatment as well.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan lang=\"EN-US\"\u003eUsual adult dose range: 75mg to 125mg once daily on days 1 to 21 of each 28-day cycle; the usual starting dose is 125mg once daily.\u003c\/span\u003e\u003c\/p\u003e","brand":"Find-A-Drug","offers":[{"title":"Default Title","offer_id":63547338293617,"sku":"52067","price":66.0,"currency_code":"NZD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1006\/1371\/8385\/files\/meds-compressed_5741bd6b-309e-40dc-8a0a-bd5e5f9a3d85.png?v=1786428352"},{"product_id":"ribociclib-200-mg","title":"Ribociclib 200mg","description":"\u003cp\u003e\u003cspan lang=\"EN-US\"\u003eRibociclib is used with an aromatase inhibitor after surgery for HR-positive, HER2-negative stage II or III early breast cancer when there is a high risk of the cancer coming back.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan lang=\"EN-US\"\u003eIt is also used with an aromatase inhibitor or fulvestrant for HR-positive, HER2-negative breast cancer that is advanced or has spread.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan lang=\"EN-US\"\u003eUsual adult dose range: 200mg to 600mg once daily on days 1 to 21 of each 28-day cycle; the starting dose is commonly 600mg for metastatic disease or 400mg for some early breast cancer regimens.\u003c\/span\u003e\u003c\/p\u003e","brand":"Find-A-Drug","offers":[{"title":"Default Title","offer_id":63547338588529,"sku":"52074","price":73.0,"currency_code":"NZD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1006\/1371\/8385\/files\/meds-compressed_4a5af804-12c0-4656-a790-98445e86a532.png?v=1786428811"},{"product_id":"tucatinib-150-mg","title":"Tucatinib 150mg","description":"\u003cp\u003e\u003cspan lang=\"EN-US\"\u003eTucatinib is used with trastuzumab and capecitabine for HER2-positive breast cancer that is advanced or has spread after earlier HER2-directed treatments, including in some people with brain metastases.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan lang=\"EN-US\"\u003eIt is also used with trastuzumab for RAS wild-type, HER2-positive colorectal cancer that has spread after standard chemotherapy.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan lang=\"EN-US\"\u003eUsual adult dose range: 150mg to 300mg twice daily; the usual starting dose is 300mg twice daily with trastuzumab and capecitabine.\u003c\/span\u003e\u003c\/p\u003e","brand":"Find-A-Drug","offers":[{"title":"Default Title","offer_id":63547340489073,"sku":"52151","price":150.0,"currency_code":"NZD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1006\/1371\/8385\/files\/meds-compressed_23e2b93f-e592-46c9-a790-3de8345eae0e.png?v=1786432546"},{"product_id":"elacestrant-86-mg","title":"Elacestrant  86mg","description":"\u003cp\u003e\u003cspan lang=\"EN-US\"\u003eElacestrant is used for postmenopausal women or adult men with ER-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer after at least one earlier hormone-based treatment has stopped working.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan lang=\"EN-US\"\u003eUsual adult dose range: 172mg to 345mg once daily with food; the usual starting dose is 345mg once daily, with lower doses used if side effects occur.\u003c\/span\u003e\u003c\/p\u003e","brand":"Find-A-Drug","offers":[{"title":"Default Title","offer_id":63547340718449,"sku":"52160","price":159.0,"currency_code":"NZD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1006\/1371\/8385\/files\/meds-compressed_a2caccf6-307e-4ded-acaf-1ea27a06f3e1.png?v=1786419001"},{"product_id":"elacestrant-345-mg","title":"Elacestrant  345mg","description":"\u003cp\u003e\u003cspan lang=\"EN-US\"\u003eElacestrant is used for postmenopausal women or adult men with ER-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer after at least one earlier hormone-based treatment has stopped working.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan lang=\"EN-US\"\u003eUsual adult dose range: 172mg to 345mg once daily with food; the usual starting dose is 345mg once daily, with lower doses used if side effects occur.\u003c\/span\u003e\u003c\/p\u003e","brand":"Find-A-Drug","offers":[{"title":"Default Title","offer_id":63547340751217,"sku":"52161","price":160.0,"currency_code":"NZD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1006\/1371\/8385\/files\/meds-compressed_00392c2e-bf23-4807-8851-d7bc19a8e3c5.png?v=1786418986"},{"product_id":"capivasertib-160-mg","title":"Capivasertib 160mg","description":"\u003cp\u003e\u003cspan lang=\"EN-US\"\u003eCapivasertib is used with fulvestrant for HR-positive, HER2-negative breast cancer that is locally advanced or has spread, has a PIK3CA, AKT1, or PTEN gene change, and has worsened after hormone-based treatment.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan lang=\"EN-US\"\u003eUsual adult dose range: 200mg to 400mg twice daily on a 4-days-on, 3-days-off weekly schedule; the usual starting dose is 400mg twice daily.\u003c\/span\u003e\u003c\/p\u003e","brand":"Find-A-Drug","offers":[{"title":"Default Title","offer_id":63547340816753,"sku":"52163","price":162.0,"currency_code":"NZD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1006\/1371\/8385\/files\/meds-compressed_fa94f975-2da4-4f8b-adea-63b6da4c532f.png?v=1786418752"},{"product_id":"capivasertib-200-mg","title":"Capivasertib 200mg","description":"\u003cp\u003e\u003cspan lang=\"EN-US\"\u003eCapivasertib is used with fulvestrant for HR-positive, HER2-negative breast cancer that is locally advanced or has spread, has a PIK3CA, AKT1, or PTEN gene change, and has worsened after hormone-based treatment.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan lang=\"EN-US\"\u003eUsual adult dose range: 200mg to 400mg twice daily on a 4-days-on, 3-days-off weekly schedule; the usual starting dose is 400mg twice daily.\u003c\/span\u003e\u003c\/p\u003e","brand":"Find-A-Drug","offers":[{"title":"Default Title","offer_id":63547340849521,"sku":"52164","price":163.0,"currency_code":"NZD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1006\/1371\/8385\/files\/meds-compressed_e875f3c6-f461-4eff-839b-b6436b7d96a2.png?v=1786418765"}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1006\/1371\/8385\/collections\/09_breast.jpg?v=1785661785","url":"https:\/\/find-a-drug.com\/collections\/breast.oembed","provider":"Find-A-Drug","version":"1.0","type":"link"}